343 related articles for article (PubMed ID: 32983141)
1. Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection.
Pal A; Gowdy KM; Oestreich KJ; Beck M; Shaikh SR
Front Immunol; 2020; 11():1997. PubMed ID: 32983141
[TBL] [Abstract][Full Text] [Related]
2. Specialized pro-resolving mediator network: an update on production and actions.
Chiang N; Serhan CN
Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
[TBL] [Abstract][Full Text] [Related]
3. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19.
Rogero MM; Leão MC; Santana TM; Pimentel MVMB; Carlini GCG; da Silveira TFF; Gonçalves RC; Castro IA
Free Radic Biol Med; 2020 Aug; 156():190-199. PubMed ID: 32653511
[TBL] [Abstract][Full Text] [Related]
4. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
5. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.
Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V
Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803
[TBL] [Abstract][Full Text] [Related]
6. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
7. Can Bioactive Lipids Inactivate Coronavirus (COVID-19)?
Das UN
Arch Med Res; 2020 Apr; 51(3):282-286. PubMed ID: 32229155
[TBL] [Abstract][Full Text] [Related]
8. The need for precision nutrition, genetic variation and resolution in Covid-19 patients.
Simopoulos AP; Serhan CN; Bazinet RP
Mol Aspects Med; 2021 Feb; 77():100943. PubMed ID: 33551236
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and cancer: start the resolution!
Barksdale C; Kipper FC; Tripathy S; Subbian S; Serhan CN; Panigrahy D
Cancer Metastasis Rev; 2022 Mar; 41(1):1-15. PubMed ID: 35190921
[TBL] [Abstract][Full Text] [Related]
10. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection.
Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M
Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665
[TBL] [Abstract][Full Text] [Related]
11. Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm.
Lee CH
Arch Pharm Res; 2021 Jan; 44(1):84-98. PubMed ID: 33398691
[TBL] [Abstract][Full Text] [Related]
12. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection.
Huizinga GP; Singer BH; Singer K
Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32880654
[TBL] [Abstract][Full Text] [Related]
13. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
El-Missiry MA; El-Missiry ZMA; Othman AI
Eur J Pharmacol; 2020 Sep; 882():173329. PubMed ID: 32615182
[TBL] [Abstract][Full Text] [Related]
14. Specialized proresolving mediators in infection and lung injury.
Sandhaus S; Swick AG
Biofactors; 2021 Jan; 47(1):6-18. PubMed ID: 33249673
[TBL] [Abstract][Full Text] [Related]
15. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
[TBL] [Abstract][Full Text] [Related]
16. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.
Kwon Y
Mol Nutr Food Res; 2020 Feb; 64(4):e1900824. PubMed ID: 31797565
[TBL] [Abstract][Full Text] [Related]
17. Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity.
Pasquarelli-do-Nascimento G; Braz-de-Melo HA; Faria SS; Santos IO; Kobinger GP; Magalhães KG
Front Endocrinol (Lausanne); 2020; 11():530. PubMed ID: 32849309
[TBL] [Abstract][Full Text] [Related]
18. Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation.
Ferreira I; Falcato F; Bandarra N; Rauter AP
Molecules; 2022 Mar; 27(5):. PubMed ID: 35268778
[TBL] [Abstract][Full Text] [Related]
19. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.
Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS
Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933
[TBL] [Abstract][Full Text] [Related]
20. ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities.
Zamorano Cuervo N; Grandvaux N
Elife; 2020 Nov; 9():. PubMed ID: 33164751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
